Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet + B cells.
Krisztian CsomosBoglarka UjhaziPeter BlazsoJose L HerreraChristopher M TiptonTomoki KawaiSumai GordonMaryssa EllisonKevin WuMatthew StowellLauren HaynesRachel CruzBence ZakotaJohnny NguyenMichelle AltrichChristoph Bruno GeierSvetlana SharapovaJoseph F DassoJennifer W LeidingGrace A SmithWaleed Al HerzMayra de Barros DornaOlajumoke FadugbaEva FronkovaVeronika KanderovaMichael SvatoňSarah E HenricksonJoseph D HernandezTaco KuijpersSnezhina Mihailova KandilarovaElizaveta NaumovaTomas MilotaAnna SedivaDespina MoshousBenedicte NevenTara SacoRavishankar SargurSinisa SavicJohn SleasmanGauri SunkersettBrant R WardMasanobu KomatsuStefania PittalugaAttila KumanovicsManish J ButteMichael P CancroShiv S PillaiEric MeffreLuigi Daniele NotarangeloJolan Eszter WalterPublished in: Nature immunology (2022)
The recombination-activating genes (RAG) 1 and 2 are indispensable for diversifying the primary B cell receptor repertoire and pruning self-reactive clones via receptor editing in the bone marrow; however, the impact of RAG1/RAG2 on peripheral tolerance is unknown. Partial RAG deficiency (pRD) manifesting with late-onset immune dysregulation represents an 'experiment of nature' to explore this conundrum. By studying B cell development and subset-specific repertoires in pRD, we demonstrate that reduced RAG activity impinges on peripheral tolerance through the generation of a restricted primary B cell repertoire, persistent antigenic stimulation and an inflammatory milieu with elevated B cell-activating factor. This unique environment gradually provokes profound B cell dysregulation with widespread activation, remarkable extrafollicular maturation and persistence, expansion and somatic diversification of self-reactive clones. Through the model of pRD, we reveal a RAG-dependent 'domino effect' that impacts stringency of tolerance and B cell fate in the periphery.
Keyphrases
- late onset
- bone marrow
- cell fate
- early onset
- genome wide
- signaling pathway
- immune response
- mesenchymal stem cells
- gene expression
- oxidative stress
- dna damage
- chemotherapy induced
- transcription factor
- autism spectrum disorder
- intellectual disability
- peripheral blood
- binding protein
- genome wide identification
- smoking cessation
- bioinformatics analysis